Schwartzman, Sergio

Publications

Sort by

Co-Author Network

selected publications

Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical Trials. JAMA dermatology. 2025 Academic Article GET IT
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events. Dermatology and therapy. 2025 Academic Article GET IT
Times cited: 1
Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies. Expert opinion on drug safety. 2024 Academic Article GET IT
Times cited: 1
Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis. Journal of the American Academy of Dermatology. 2024 Guideline GET IT
Times cited: 2
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials. Arthritis research & therapy. 2024 Academic Article GET IT
Times cited: 12
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 2024 Guideline GET IT
Times cited: 3
Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation. Journal of the American Academy of Dermatology. 2023 Academic Article GET IT
Times cited: 4
National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine. JAAD international. 2023 Academic Article GET IT
Times cited: 3
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study. BMC rheumatology. 2023 Academic Article GET IT
Times cited: 2
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of rheumatology. 2022 Review GET IT
Times cited: 18
Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review. Medicine. 2022 Review GET IT
Times cited: 5
Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials. Rheumatology and therapy. 2022 Academic Article GET IT
Times cited: 13
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Arthritis research & therapy. 2022 Academic Article GET IT
Times cited: 17
Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset. ACR open rheumatology. 2022 Academic Article GET IT
Times cited: 16
Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs. RMD open. 2022 Academic Article GET IT
Times cited: 31
A Road Map of the Axial Spondyloarthritis Continuum. Mayo Clinic proceedings. 2021 Review GET IT
Times cited: 18
Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. 2021 GET IT
Times cited: 1
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study. Rheumatology and therapy. 2021 Academic Article GET IT
Times cited: 7
MRI Assessment of Sacroiliitis With High-Resolution Protocol. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2021 Academic Article GET IT
Times cited: 2
Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study. International journal of rheumatic diseases. 2021 Academic Article GET IT
Times cited: 5
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. Journal of the American Academy of Dermatology. 2021 Guideline GET IT
Times cited: 88
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. Rheumatology (Oxford, England). 2020 Review GET IT
Times cited: 61
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1. Journal of the American Academy of Dermatology. 2020 Guideline GET IT
Times cited: 45
Association of High Serum Interleukin-6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis. Arthritis & rheumatology (Hoboken, N.J.). 2020 Academic Article GET IT
Times cited: 42
Controversies in Rheumatology. Rheumatic diseases clinics of North America. 2019 Editorial Article GET IT
Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?. Rheumatic diseases clinics of North America. 2019 Review GET IT
Times cited: 10
ALIGN PsA: Advancing a Multidisciplinary Approach in PsA. Seminars in cutaneous medicine and surgery. 2018 Review GET IT
Times cited: 10
Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists. American journal of clinical dermatology. 2018 Review GET IT
Times cited: 45
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review. JAMA dermatology. 2018 Academic Article GET IT
Times cited: 139
Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy. Advances in therapy. 2017 Academic Article GET IT
Times cited: 53
Economic impact of biologic utilization patterns in patients with psoriatic arthritis. Clinical rheumatology. 2017 Academic Article GET IT
Times cited: 14
IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote T_H17-dependent inflammation. Science translational medicine. 2017 Academic Article GET IT
Times cited: 253
Advancements in the management of uveitis. Best practice & research. Clinical rheumatology. 2016 Review GET IT
Times cited: 35
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group. Clinical rheumatology. 2016 Academic Article GET IT
Times cited: 26
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.). 2016 Guideline GET IT
Times cited: 790
The Use of Biologic Therapies in Uveitis. Clinical reviews in allergy & immunology. 2015 Review GET IT
Times cited: 18
Recognizing and managing comorbidities in psoriatic arthritis. Current opinion in rheumatology. 2015 Review GET IT
Times cited: 154
Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations. The Journal of rheumatology. 2014 Review GET IT
Times cited: 63
Whipple's disease. Rheumatic diseases clinics of North America. 2013 Review GET IT
Times cited: 10
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2. Dermatology and therapy. 2012 Academic Article GET IT
Times cited: 40
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1. Dermatology and therapy. 2012 Academic Article GET IT
Times cited: 2
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis and rheumatism. 2011 Academic Article GET IT
Times cited: 59
Patient perceptions concerning pain management in the treatment of rheumatoid arthritis. The Journal of international medical research. 2010 Academic Article GET IT
Times cited: 134
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach. Journal of the American Academy of Dermatology. 2009 Academic Article GET IT
Times cited: 27
Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients. Annals of the rheumatic diseases. 2006 Academic Article GET IT
Times cited: 140
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?. Arthritis research & therapy. 2004 Review GET IT
Times cited: 34
Does route of administration affect the outcome of TNF antagonist therapy?. Arthritis research & therapy. 2004 Review GET IT
Times cited: 75
Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis and rheumatism. 2000 Academic Article GET IT
Times cited: 107
Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis and rheumatism. 2000 Academic Article GET IT
Times cited: 183
Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Seminars in arthritis and rheumatism. 1997 Review GET IT
Times cited: 164
Carbohydrates on human Fc gamma receptors. Interdependence of the classical IgG and nonclassical lectin-binding sites on human Fc gamma RIII expressed on neutrophils. Journal of immunology (Baltimore, Md. : 1950). 1989 Academic Article GET IT
Times cited: 44
Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma. Clinical and experimental immunology. 1988 Academic Article GET IT
Times cited: 13
Idiopathic hypertrophic osteoarthropathy without pachyderma and with acrolysis. 1982 GET IT
Times cited: 3

more ...

less ...

Background

education and training

B.A., State University of New York at Binghamton 78
M.D., Mount Sinai School of Medicine 1982

Contact

full name

Sergio Schwartzman

primary email

ses2003@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Sergio Schwartzman Clinical Associate Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage